Clinical Trials in Ohio

Showing 20721-20740 of 20,938 trials

Study of Nitazoxanide in the Treatment of Clostridium Difficile Colitis

NCT00417872

The primary objective is to demonstrate non-inferiority of nitazoxanide administered 500 mg b.i.d compared to metronidazole administered 250 mg q.i.d. in resolving symptoms of Clotridium difficile colitis after seven days of treatment. Secondary objectives are to provide information on the times from first dose to last unformed stool and resolution of symptoms of colitis, the sustained response rates for the different tratment groups and the effect of treatment on Clostridium difficile toxin enzyme immunoassay/culture results during hospitalization.

Clostridium Difficile

Romark Laboratories L.C.114 participantsStarted Jan 2004

St. Petersburg, Florida, United States • Marietta, Georgia, United States • Columbus, Ohio, United States +4 more locations

COMPLETEDPhase 232 miles

To Evaluate the Long-Term Safety of Pregabalin in Refractory Partial Epilepsy.

NCT00141414

To evaluate the long-term safety of pregabalin in refractory partial epilepsy.

Epilepsy, Partial

Pfizer82 participantsStarted Nov 1997

Little Rock, Arkansas, United States • Los Angeles, California, United States • Stanford, California, United States +22 more locations

Study of Nitazoxanide in the Treatment of Clostridium Difficile Colitis

To Evaluate the Long-Term Safety of Pregabalin in Refractory Partial Epilepsy.

Find Trials by Condition in Ohio

Evaluation of Intravenous Levosimendan Efficacy in the Short Term Treatment of Decompensated Chronic Heart Failure.

A Phase 2, Randomized, Open-Label Study Of Single Agent CI-1033 In Patients With Advanced Non-Small Cell Lung Cancer

Study Evaluating the Safety & Efficacy of DVS-223 SR for Relief of Vasomotor Symptoms Associated With Menopause

Study to Evaluate the Efficacy, Safety, and Tolerability of E7070 in Metastatic Breast Cancer Patients

Evaluation of Argatroban Injection in Pediatric Patients Requiring Anticoagulant Alternatives to Heparin

Study Evaluating MST-997 in Advanced Malignant Solid Tumors

Study for Patients With Relapsed or Refractory Acute Myeloid Leukemia (AML)

Clinical Investigation of the SelectSecure Pacing Lead

SP01A: The Study of an Oral Entry Inhibitor in Treatment-Experienced HIV Patients

Study Of An Oral Tyrosine Kinase Inhibitor Of VEGFR-2 To Treat Small-Volume Ovarian, Peritoneal, Fallopian Tube Cancer

A Study to Evaluate the Single-Agent Lenalidomide in Subjects With Recurrent Non-Small-Cell Lung Cancer

An Efficacy Evaluation of 2 Different Bowel Cleansing Preparations in Adult Subjects

T Cell Immunotherapy for Multiple Myeloma Patients Undergoing a Bone Marrow Transplant

A Study of Pemetrexed in Small Cell Lung Cancer, Which Has Returned

APC-231 Once a Day (QD) for 7 Days vs. Penicillin Taken Four Times a Day (QID) in Pediatric Patients With Strep Throat

Chemotherapy for Patients With Advanced Solid Tumors or Non-Hodgkin's Lymphoma

Safety and Immunogenicity of Recombinant DNA and Adenovirus Expressing L523S Protein in Early Stage Non-Small Cell Lung Cancer

Bipolar Depression Study: Bipolar Depression Assessment Study on Treatment Response